To include your compound in the COVID-19 Resource Center, submit it here.

TMC207: Phase II data

Data from 160 newly diagnosed MDR-TB patients in the second stage of a double-blind Phase II trial showed that TMC207 met the

Read the full 226 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE